EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease

Jessica Winarto iD, Dae-Geun Song iD, Cheol-Ho Pan iD

International Journal of Molecular Sciences · 03.05.2023 · 24 (9) · 8203

DOI: 10.3390/ijms24098203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.05.2023. Verfasst von Jessica Winarto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology, Seoul 02792, Republic of Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Ministry of Oceans and Fisheries, Ministry of Trade, Industry & Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic liver disease (CLD) has emerged as a leading cause of human deaths. It caused 1.32 million deaths in 2017, which affected men more than women by a two-to-one ratio. There are various causes of CLD, including obesity, excessive alcohol consumption, and viral infection. Among them, non-alcoholic fatty liver disease (NAFLD), one of obesity-induced liver diseases, is the major cause, representing the cause of more than 50% of cases. Fucoxanthin, a carotenoid mainly found in brown seaweed, exhibits various biological activities against NAFLD. Its role in NAFLD appears in several mechanisms, such as inducing thermogenesis in mitochondrial homeostasis, altering lipid metabolism, and promoting anti-inflammatory and anti-oxidant activities. The corresponding altered signaling pathways are the β3-adorenarine receptor (β3Ad), proliferator-activated receptor gamma coactivator (PGC-1), adenosine monophosphate-activated protein kinase (AMPK), peroxisome proliferator-activated receptor (PPAR), sterol regulatory element binding protein (SREBP), nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), protein kinase B (AKT), SMAD2/3, and P13K/Akt pathways. Fucoxanthin also exhibits anti-fibrogenic activity that prevents non-alcoholic steatohepatitis (NASH) development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMaleHumansFemaleProto-Oncogene Proteins c-aktXanthophyllsLipid MetabolismObesityLiver

Stichwörter der Autor:innen

fibrosisfucoxanthinlipidlivernon-alcoholicobesitythermogenesis

Substanzen

Proto-Oncogene Proteins c-aktfucoxanthinXanthophylls

Autor:innen und Institutionen

  • Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology, Seoul 02792, Republic of Korea.
  • Natural Product Informatics Research Center, KIST Gangneung Institute of Natural Products, Gangneung 25451, Republic of Korea.
  • Microalgae Ask US Co., Ltd., Gangneung 25441, Republic of Korea.

ORCID-Profile: Jessica Winarto, Dae-Geun Song, Cheol-Ho Pan

Förderung

  • Ministry of Trade, Industry and Energy
  • Ministry of Oceans and Fisheries
  • Ministry of Trade, Industry & Energy

Zitieren

APA

Winarto, J., Song, D. G., & Pan, C. H. (2023). The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 24(9), 8203. https://doi.org/10.3390/ijms24098203

Vancouver

Winarto J, Song DG, Pan CH. The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 2023;24(9):8203. doi:10.3390/ijms24098203

BibTeX
@article{Winarto2023,
  author = {Winarto, Jessica and Song, Dae-Geun and Pan, Cheol-Ho},
  title = {The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {9},
  pages = {8203},
  doi = {10.3390/ijms24098203}
}
Kostenlos starten →